Cargando…

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease

BACKGROUND AND AIMS: The disease-related knowledge levels in patients with inflammatory bowel disease (IBD) are important because it could affect the self-management ability and adaptive coping strategies. We set out to determine whether higher levels of disease-related knowledge reduce medical acce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jihye, Yoon, Hyuk, Shin, Cheol Min, Park, Young Soo, Kim, Nayoung, Lee, Dong Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274391/ https://www.ncbi.nlm.nih.gov/pubmed/32502199 http://dx.doi.org/10.1371/journal.pone.0233654

Ejemplares similares

Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study
por: Park, Jihye, et al.
Publicado: (2022)

The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease
por: Jun, Jae Chang, et al.
Publicado: (2019)

Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease
por: Yoon, Hyuk, et al.
Publicado: (2019)

Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics
por: Huh, Gunn, et al.
Publicado: (2019)

Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics
por: Huh, Gunn, et al.
Publicado: (2019)

Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls
por: Heo, Min, et al.
Publicado: (2023)

Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease
por: Han, Yoo Min, et al.
Publicado: (2017)

Distribution of small bowel involvement and its association with clinical outcomes in patients with Crohn’s disease
por: Park, Jin, et al.
Publicado: (2023)

Comparison of loss of response between anti-tumor necrosis factor alone and combined use with immunomodulators in patients with inflammatory bowel disease
por: Hong, Seung Wook, et al.
Publicado: (2021)

10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification – a nationwide population-based study
por: Koo, Hee Moon, et al.
Publicado: (2023)

Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study
por: Shin, Dong Woo, et al.
Publicado: (2018)

Sex difference in bowel preparation quality and colonoscopy time
por: Hwang, Young-Jae, et al.
Publicado: (2021)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Higher Morbidity of Monogenic Inflammatory Bowel Disease Compared to the Adolescent Onset Inflammatory Bowel Disease
por: Kim, Kwang Yeon, et al.
Publicado: (2018)

Medication-Related Knowledge and Medication Adherence in Pediatric and Adolescent Patients with Inflammatory Bowel Disease
por: Lim, Jong Keon, et al.
Publicado: (2020)

Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial
por: Yoon, Hyuk, et al.
Publicado: (2015)

Incidence and Prevalence of Inflammatory Bowel Disease across Asia
por: Park, Jihye, et al.
Publicado: (2021)

A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study
por: Lee, Ju Yup, et al.
Publicado: (2022)

Is Atrial Fibrillation a Risk Factor for Gastroesophageal Reflux Disease Occurrence?
por: Hwang, Jae Jin, et al.
Publicado: (2015)

Insufficient Knowledge of Korean Gastroenterologists Regarding the Vaccination of Patients with Inflammatory Bowel Disease
por: Jung, Yoon Suk, et al.
Publicado: (2014)

Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study
por: Cho, Jae Ho, et al.
Publicado: (2020)

Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial
por: Cho, Jae Ho, et al.
Publicado: (2020)

Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?
por: Park, Jihye
Publicado: (2022)

How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?
por: Park, Jihye
Publicado: (2023)

Usefulness of Examining Various Patient-Reported Outcomes in Predicting Endoscopic Mucosal Healing in Ulcerative Colitis
por: Min Moon, Jung, et al.
Publicado: (2022)

Sprayable nanomicelle hydrogels and inflammatory bowel disease patient cell chips for development of intestinal lesion-specific therapy
por: Yoon, Hyo-Jin, et al.
Publicado: (2022)

Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men
por: Choi, Yoon Jin, et al.
Publicado: (2018)

Novel treatments for inflammatory bowel disease
por: Lee, Hyo Sun, et al.
Publicado: (2018)

Resting heart rate is associated with colorectal advanced adenoma
por: Park, Jihye, et al.
Publicado: (2021)

Risk of Heart Disease after Cholecystectomy: A Nationwide Population-Based Cohort Study in South Korea
por: Kim, Yoo Jin, et al.
Publicado: (2021)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
por: Park, Jihye, et al.
Publicado: (2021)

Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Park, Chan Hyuk, et al.
Publicado: (2022)

Total polyp number may be more important than size and histology of polyps for prediction of metachronous high-risk colorectal neoplasms
por: Yoon, Hyuk, et al.
Publicado: (2022)

Gut Microbiome in Probable Intestinal Tuberculosis and Changes following Anti-Tuberculosis Treatment
por: Yoon, Hyuk, et al.
Publicado: (2022)

Physical activity and quality of life of patients with inflammatory bowel disease
por: Kim, Bun, et al.
Publicado: (2021)

Impact of Education on School Nurses’ Knowledge of Inflammatory Bowel Disease
por: Kim, Eun Soo, et al.
Publicado: (2019)

Anti-integrin therapy for inflammatory bowel disease
por: Park, Sung Chul, et al.
Publicado: (2018)

Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?
por: Park, Yong Eun, et al.
Publicado: (2020)

Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients
por: Lee, Sun Min, et al.
Publicado: (2021)

Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
por: Park, Jihye, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bq9ofu1n0jt9j23dnk2l5cvnjh